Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.13 HKD
238.75 M HKD
1.47 B HKD
388.39 M
About JACOBSON PHARMA CO LTD
Sector
CEO
Kwong Yip Sum
Headquarters
Hong Kong
Website
Founded
2016
FIGI
BBG00DRGW9B9
Jacobson Pharma Corp. Ltd. engages in the development, production, marketing, and sale of generic drugs. It operates through the Generic Drugs and Branded Healthcare segments. The Generic Drugs segment develops, manufactures, and distributes a host of off-patent medicines for various therapeutic use. The Branded Healthcare segment develops, manufactures, and distributes branded medicines, proprietary Chinese medicines, and health and wellness products. The company was founded by Kwong Yip Sum on February 16, 2016 and is headquartered in Hong Kong.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2633 is 1.03 HKD — it has decreased by −0.96% in the past 24 hours. Watch JACOBSON PHARMA CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange JACOBSON PHARMA CO LTD stocks are traded under the ticker 2633.
2633 stock has risen by 5.10% compared to the previous week, the month change is a 25.61% rise, over the last year JACOBSON PHARMA CO LTD has showed a 60.94% increase.
2633 reached its all-time high on Aug 8, 2017 with the price of 2.28 HKD, and its all-time low was 0.44 HKD and was reached on Dec 17, 2021. View more price dynamics on 2633 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2633 stock is 6.00% volatile and has beta coefficient of 0.29. Track JACOBSON PHARMA CO LTD stock price on the chart and check out the list of the most volatile stocks — is JACOBSON PHARMA CO LTD there?
Today JACOBSON PHARMA CO LTD has the market capitalization of 2.05 B, it has decreased by −1.98% over the last week.
Yes, you can track JACOBSON PHARMA CO LTD financials in yearly and quarterly reports right on TradingView.
JACOBSON PHARMA CO LTD is going to release the next earnings report on Jun 19, 2025. Keep track of upcoming events with our Earnings Calendar.
2633 net income for the last half-year is 140.29 M HKD, while the previous report showed 112.93 M HKD of net income which accounts for 24.23% change. Track more JACOBSON PHARMA CO LTD financial stats to get the full picture.
JACOBSON PHARMA CO LTD dividend yield was 9.32% in 2023, and payout ratio reached 44.25%. The year before the numbers were 5.34% and 39.45% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 31, 2024, the company has 1.72 K employees. See our rating of the largest employees — is JACOBSON PHARMA CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JACOBSON PHARMA CO LTD EBITDA is 477.71 M HKD, and current EBITDA margin is 29.29%. See more stats in JACOBSON PHARMA CO LTD financial statements.
Like other stocks, 2633 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JACOBSON PHARMA CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JACOBSON PHARMA CO LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JACOBSON PHARMA CO LTD stock shows the buy signal. See more of JACOBSON PHARMA CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.